SEC Form 4 · accession 0001140361-16-082894
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean Jacques Bienaime
Officer — Chief Executive Officer · Director
Period of report
Aug 3, 2016
Accepted (ET)
Oct 17, 2016 · 7:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 3, 2016 | G | 400 | $0.00 | D | 378,184 | D | |
| Common StockF2 | Aug 4, 2016 | G | 500 | $0.00 | D | 377,684 | D | |
| Common StockF3 | Aug 24, 2016 | G | 200 | $0.00 | D | 377,484 | D | |
| Common StockF4,F5 | Oct 13, 2016 | M | 53,125 | $38.59 | A | 376,493 | D | |
| Common StockF4,F6,F5 | Oct 13, 2016 | S | 53,125 | $86.9753 | D | 323,368 | D | |
| Common StockF4 | Oct 14, 2016 | M | 11,000 | $17.86 | A | 334,368 | D | |
| Common StockF4,F7 | Oct 14, 2016 | S | 11,000 | $86.8922 | D | 323,368 | D | |
| Common Stock | holding | — | — | — | 25,758 | I | Shares held by Bienaime Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy Common Stock)F4,F8 | $38.59 | Oct 13, 2016 | M | 53,125 | D | Nov 22, 2008 | May 21, 2018 | Common Stock | 53,125 | 212,500 | D |
| Stock Option (right to buy Common Stock)F4,F8 | $17.86 | Oct 14, 2016 | M | 11,000 | D | Jun 17, 2009 | Dec 16, 2018 | Common Stock | 11,000 | 11,000 | D |
Explanation of responses
- F1On August 3, 2016, the reporting person gifted 400 shares to an educational institution.
- F2On August 4, 2016, the reporting person gifted 500 shares to an educational institution.
- F3On August 24, 2016, the reporting person gifted 200 shares to an educational institution.
- F4Trade made pursuant to a 10b5-1 plan executed on June 9, 2016. Mr. Bienaime's former spouse will receive the net proceeds from the shares sold in this transaction in connection with cash payments owed to her pursuant to a martial separation agreement between her and Mr. Bienaime.
- F5The number of shares reflects transfers made by Mr. Bienaime to his former spouse prior to October 13, 2016, of a total of 54,116 shares pursuant to a marital separation agreement.
- F6The price in column 4 is the weighted average price. The price actually received ranged from $86.15 to $88.23. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- F7The price in column 4 is the weighted average price. The price actually received ranged from $86.41 to $87.78. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- F8Reflects the number of stock options outstanding after the transaction from this specific stock option grant.